Retatrutide 20mg Alluvi

A 20mg Retatrutide formulation supplied in a pre-filled research device, provided exclusively for controlled laboratory R&D applications. Delivered in sealed format to support compound stability analysis, formulation studies, and delivery mechanism evaluation.

Alluvi 20mg Retatrutide

What is Alluvi 20mg Retatrutide

Alluvi 20mg Retatrutide refers to a product marketed as containing retatrutide, a new and investigational weight loss medication. Retatrutide is not yet an approved drug for general use, but it’s generating strong interest due to promising clinical trial results in the treatment of obesity and metabolic conditions. Alluvi reta pen for sale.

Alluvi healthcare retatrutide pens is known as a triple hormone receptor agonist, meaning it activates three key hormonal pathways:

• GLP-1 receptor (Glucagon-like peptide-1)

• GIP receptor (Glucose-dependent insulinotropic polypeptide)

• Glucagon receptor

This combination is designed to significantly reduce appetite, increase satiety, improve blood sugar regulation, and possibly increase energy expenditure — all of which support substantial weight loss and metabolic improvement.